Education
About Us
Working with TipRanks
Follow Us
Immunic (IMUX)
NASDAQ:IMUX
Total Valuation
Immunic has a market cap or net worth of $80.86M. The enterprise value is -$60.64M.
Market Cap$80.86M
Enterprise Value-$60.64M
Share Statistics
Immunic has 95,817,535 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding95,817,535
Owned by Insiders0.96%
Owned by Institutions28.99%
Financial Efficiency
Immunic’s return on equity (ROE) is -5.45 and return on invested capital (ROIC) is -504.56%.
Return on Equity (ROE)-5.45
Return on Assets (ROA)-2.46
Return on Invested Capital (ROIC)-504.56%
Return on Capital Employed (ROCE)-5.25
Revenue Per Employee0.00
Profits Per Employee-1.10M
Employee Count91
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Immunic is -1.00. Immunic’s PEG ratio is -0.01.
PE Ratio-1.00
PS Ratio0.00
PB Ratio0.39
Price to Fair Value5.44
Price to FCF-0.68
Price to Operating Cash Flow-0.68
PEG Ratio-0.01
Income Statement
In the last 12 months, Immunic had revenue of 0.00 and earned -100.51M in profits. Earnings per share was -1.00.
Revenue0.00
Gross Profit0.00
Operating Income-98.05M
Pretax Income-100.51M
Net Income-100.51M
EBITDA-100.37M
Earnings Per Share (EPS)-1.00
Cash Flow
In the last 12 months, operating cash flow was -82.57M and capital expenditures -280.00K, giving a free cash flow of -82.85M billion.
Operating Cash Flow-82.57M
Free Cash Flow-82.85M
Free Cash Flow per Share-0.86
Dividends & Yields
Immunic pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.58
52-Week Price Change-29.82%
50-Day Moving Average0.95
200-Day Moving Average1.16
Relative Strength Index (RSI)42.45
Average Volume (3m)1.83M
Important Dates
Immunic upcoming earnings date is Aug 7, 2025, TBA Not Confirmed.
Last Earnings DateMay 8, 2025
Next Earnings DateAug 7, 2025
Ex-Dividend Date―
Financial Position
Immunic as a current ratio of 1.77, with Debt / Equity ratio of 1.37%
Current Ratio1.77
Quick Ratio1.77
Debt to Market Cap0.00
Net Debt to EBITDA0.35
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Immunic has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Immunic EV to EBITDA ratio is -0.65, with an EV/FCF ratio of -0.77.
EV to Sales0.00
EV to EBITDA-0.65
EV to Free Cash Flow-0.77
EV to Operating Cash Flow-0.77
Balance Sheet
Immunic has $14.30M in cash and marketable securities with $210.00K in debt, giving a net cash position of -$14.09M billion.
Cash & Marketable Securities$14.30M
Total Debt$210.00K
Net Cash-$14.09M
Net Cash Per Share-$0.15
Tangible Book Value Per Share$0.18
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Immunic is $13.80, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$13.80
Price Target Upside1625.00% Upside
Analyst ConsensusStrong Buy
Analyst Count6
Revenue Growth Forecast―
EPS Growth Forecast51.02%